Rimegepant works by blocking a protein called CGRP (calcitonin gene-related peptide) from activating receptors in the nervous system that trigger migraine attacks. It’s one of a class of drugs called “gepants,” and it’s unique in being approved for both stopping a migraine in progress and preventing future attacks. Sold under the brand name Nurtec ODT, it comes as a 75 mg tablet that dissolves on your tongue.
What CGRP Does During a Migraine
CGRP is a signaling molecule released by nerve fibers in and around your brain, particularly in a cluster of nerves called the trigeminal system. This system is responsible for sensation in your face and head. During a migraine, CGRP floods the area around these nerves, docking onto receptors that cause blood vessels to widen, surrounding tissue to become inflamed, and pain signals to amplify. The result is the throbbing, often one-sided headache along with sensitivity to light, sound, and nausea that define a migraine attack.
CGRP levels rise sharply during a migraine and drop once the pain resolves. That pattern made CGRP an obvious drug target, and rimegepant was designed to interrupt this process at the receptor level.
How Rimegepant Blocks the Signal
The main CGRP receptor is made of two protein components that sit together on the surface of nerve cells. Rimegepant binds to this receptor and physically prevents CGRP from attaching, which stops the downstream cascade of inflammation and pain signaling. It also blocks a second, related receptor called the AMY1 receptor, though it’s roughly 17 to 30 times more potent at the primary CGRP receptor. Both receptor types are found in the trigeminal ganglia, the nerve hub most implicated in migraine.
This blocking action is competitive and reversible. Rimegepant doesn’t destroy the receptor or permanently alter it. It simply occupies the binding site for as long as the drug is active in your system, then clears out. That reversibility is part of why side effects tend to be mild.
How Quickly It Works
The orally disintegrating tablet reaches peak blood concentration in about 1.5 hours, which is roughly 25 minutes faster than a conventional swallowed tablet. For acute migraine treatment, the clinically meaningful time point is two hours after dosing. In a real-world multicenter study, about 32% of patients were completely pain-free at the two-hour mark. Relief from the most bothersome accompanying symptoms was even higher: 57% were free of nausea, 53% were free of sound sensitivity, and 43% were free of light sensitivity by two hours.
What sets rimegepant apart from triptans (the older standard for acute migraine) is its long tail. The drug has an average half-life of about 11 hours, meaning it stays active in your body well beyond that initial relief window. Clinical trials have shown sustained effects through 48 hours after a single dose, which may help explain why migraine recurrence rates tend to be lower compared to shorter-acting treatments.
Rimegepant for Migraine Prevention
The same mechanism that stops an active migraine can also reduce how often migraines occur when the drug is taken on a regular schedule. For prevention, rimegepant is taken every other day rather than only when a migraine strikes. A meta-analysis of randomized controlled trials found that this regimen reduced monthly migraine days by about 1.5 days in the first four weeks compared to placebo, settling to roughly one fewer migraine day per month over longer treatment periods. That may sound modest in isolation, but for someone experiencing eight or more migraine days a month, it represents a meaningful improvement in quality of life, especially when combined with fewer severe attacks.
The American Headache Society now includes CGRP-targeting therapies as an option for migraine prevention, and gepants like rimegepant are recommended for acute migraine treatment. The VA/DoD clinical practice guidelines give rimegepant a “weak for” recommendation for acute use, noting that evidence for its preventive role is still building.
How Your Body Processes It
After the tablet dissolves on or under your tongue, rimegepant is absorbed through the digestive tract and metabolized primarily by a liver enzyme called CYP3A4. About 78% of the drug is eliminated through bile and stool, with roughly 24% cleared through urine. The 11-hour half-life means the drug is mostly out of your system within two days, which is relevant if you’re taking it only for acute attacks rather than on a prevention schedule.
Because CYP3A4 handles the bulk of metabolism, anything that strongly speeds up or slows down this enzyme will affect how much rimegepant is in your bloodstream. Strong CYP3A4 inhibitors (certain antifungals, HIV medications, and grapefruit juice in large amounts) can raise rimegepant levels to a point where side effects become more likely, so these combinations should be avoided. Moderate inhibitors require spacing doses at least 48 hours apart. On the flip side, strong CYP3A4 inducers (some seizure medications, rifampin, St. John’s wort) can clear rimegepant too quickly, reducing its effectiveness.
Side Effects
Rimegepant is well tolerated overall. The most commonly reported side effect is nausea, occurring in about 2% of patients in clinical trials. Dizziness, drowsiness, and dry mouth have also been reported, but each occurs in fewer than 5% of users and tends to be mild and short-lived. This is a notably lighter side effect profile than triptans, which can cause chest tightness, tingling, and fatigue, or than older migraine preventives like topiramate, which often causes cognitive dulling and weight changes.
The one formal contraindication is a prior hypersensitivity reaction to rimegepant or any inactive ingredient in the tablet. Delayed hypersensitivity reactions, including rash and facial swelling, have been reported rarely.
How to Take It
The orally disintegrating tablet doesn’t require water, which is practical when nausea makes swallowing a regular pill unappealing. You peel back the foil of the blister pack (don’t push the tablet through it, as it’s fragile), place it on or under your tongue, and it dissolves in seconds. For acute treatment, the dose is one 75 mg tablet, with a maximum of one tablet per 24-hour period. For prevention, the same 75 mg tablet is taken every other day.
Because it works differently from triptans, rimegepant doesn’t carry the same cardiovascular restrictions. Triptans constrict blood vessels and are generally avoided in people with heart disease or uncontrolled high blood pressure. Rimegepant has no vasoconstrictor activity, making it an option for patients who can’t safely use triptans.